Curis Price To Book vs. Price To Sales
Based on Curis' profitability indicators, Curis Inc may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Curis' ability to earn profits and add value for shareholders.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
For Curis profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Curis to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Curis Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Curis's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Curis Inc over time as well as its relative position and ranking within its peers.
Curis |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Curis. If investors know Curis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Curis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Curis Inc is measured differently than its book value, which is the value of Curis that is recorded on the company's balance sheet. Investors also form their own opinion of Curis' value that differs from its market value or its book value, called intrinsic value, which is Curis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Curis' market value can be influenced by many factors that don't directly affect Curis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Curis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Curis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Curis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Curis Inc Price To Sales vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Curis's current stock value. Our valuation model uses many indicators to compare Curis value to that of its competitors to determine the firm's financial worth. Curis Inc is rated fifth in price to book category among its peers. It is rated below average in price to sales category among its peers fabricating about 0.63 of Price To Sales per Price To Book. The ratio of Price To Book to Price To Sales for Curis Inc is roughly 1.60 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Curis by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Curis Price To Sales vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Curis |
| = | 4.32 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Curis |
| = | 2.71 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Curis Price To Sales Comparison
Curis is currently under evaluation in price to sales category among its peers.
Curis Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Curis, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Curis will eventually generate negative long term returns. The profitability progress is the general direction of Curis' change in net profit over the period of time. It can combine multiple indicators of Curis, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts. Curis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 60 people.
Curis Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Curis. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Curis position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Curis' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Curis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Use Investing Themes to Complement your Curis position
In addition to having Curis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sovereign ETFs Thematic Idea Now
Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sovereign ETFs theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Curis Stock Analysis
When running Curis' price analysis, check to measure Curis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curis is operating at the current time. Most of Curis' value examination focuses on studying past and present price action to predict the probability of Curis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curis' price. Additionally, you may evaluate how the addition of Curis to your portfolios can decrease your overall portfolio volatility.